TP53 and Seckel syndrome: One of the first hints that centrosomal defects and prolonged mitosis could activate p53 through DDR-independent pathways in vivo came from the analysis of mice deficient for SAS4/CPAP that is mutated in Seckel syndrome (Phan and Holland, 2021).